Skull Base - Long-Term fSRT Outcomes for Cavernous Sinus Meningiomas

This episode delves into the long-term outcomes of fractionated stereotactic radiotherapy (fSRT) for symptomatic WHO grade 1 cavernous sinus meningiomas. Based on the full text of a study published in the Journal of Neuro-Oncology in 2026, we examine the efficacy of fSRT in achieving local control, the rates of clinical response in patients, and the associated toxicity profiles. The study analyzes data from a specific patient population treated with this modality, providing valuable insights into its safety and effectiveness over extended follow-up periods. These findings offer important considerations for clinicians managing these challenging skull base tumors. This content is for informational purposes and does not constitute medical advice.